Cresco Labs FY2024 EPS Forecast Reduced by Atb Cap Markets

Cresco Labs Inc. (OTCMKTS:CRLBF) – Equities researchers at Atb Cap Markets dropped their FY2024 earnings estimates for shares of Cresco Labs in a note issued to investors on Sunday, November 10th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings of ($0.20) per share for the year, down from their prior estimate of ($0.17). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Atb Cap Markets also issued estimates for Cresco Labs’ Q4 2024 earnings at ($0.03) EPS and FY2025 earnings at ($0.09) EPS.

Other equities research analysts have also recently issued research reports about the stock. Ventum Cap Mkts raised shares of Cresco Labs to a “strong-buy” rating in a report on Friday, August 9th. Needham & Company LLC restated a “hold” rating on shares of Cresco Labs in a research note on Monday, August 12th. Roth Capital upgraded Cresco Labs to a “strong-buy” rating in a research note on Sunday, November 10th. Finally, Cormark cut Cresco Labs from a “moderate buy” rating to a “hold” rating in a research note on Monday. Three investment analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $2.50.

Cresco Labs Stock Performance

Shares of CRLBF stock opened at $1.40 on Wednesday. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.30 and a current ratio of 2.00. The firm has a market cap of $683.40 million, a price-to-earnings ratio of -7.20 and a beta of 1.88. Cresco Labs has a 52 week low of $1.02 and a 52 week high of $2.65. The firm’s 50-day simple moving average is $1.58 and its two-hundred day simple moving average is $1.70.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.